Gene Biotherapeutics, Inc.
Gene Biotherapeutics, Inc. (CRXM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CRXM · as of Jun 9, 2026
Key Statistics
Explore Gene Biotherapeutics, Inc. Data
crxm stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
crxm competitorsCRXM
ACCA
CRYO
EQUR
FPSUF
GLSHQStock Performance
Full HistoryAbout Gene Biotherapeutics, Inc.
Gene Biotherapeutics, Inc. is a biotechnology company in the clinical development stage, dedicated to researching and bringing to market angiogenic gene therapy treatments for cardiovascular condition…
what is gene biotherapeutics, inc. · crxm stock overview · gene biotherapeutics, inc. company profile · who is gene biotherapeutics, inc. ceo · crxm OTC · gene biotherapeutics, inc. headquarters · gene biotherapeutics, inc. business segments
About Stock Overview & Key Data
Gene Biotherapeutics, Inc. (CRXM) is a Healthcare company in the Biotechnology industry, listed on OTC since May 3, 2000. As of the latest trading session, CRXM stock price is $0.00, with a market capitalization of $6,493. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2020, Gene Biotherapeutics, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Gene Biotherapeutics, Inc. (CRXM) stock price is $0.00. The stock is traded on OTC under the ticker symbol CRXM. The 52-week range is $1.00 – $6.00.